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Glucose and glycerol compared as osmotic agents for peritoneal dialy-
sis. The potential utility of glycerol as an osmotic agent for peritoneal
dialysis was evaluated by conducting both isosmotic and hyperosmotic
exchanges in anesthetized rats. Similar exchanges were conducted
using glucose, and the results with the two agents were compared.
During hyperosmotic exchanges both agents produced significant os-
motic flow of water, but at initial molar concentrations that were equal
the flow observed with glycerol was nearly 40% less than that observed
with glucose. The lower volume transport generated by glycerol was
found to be due to its surprisingly rapid removal from peritoneal fluid
when it was present at hyperosmotic concentrations, but paradoxically
during isosmotic exchanges, when its concentration was low, glycerol
was absorbed only slightly faster than glucose. The observed increase
in peritoneal permeability when glycerol was used resulted in a twofold
increase in the caloric toad imposed per unit of water removed in
comparison with glucose.
Le glucose et le glycerol compare comme agents osmotiques pour Ia
dialyse péritoneale. L'utilité potentielle du glycerol comme agent osmo-
tique pour La dialyse peritonéale a été évaluée en effectuant des
echanges isosmotiques et hyperosmotiques chez des rats anesthésiés.
Des échanges similaires ont été faits en utilisant du glucose, et les
resultats avec les deux agents ont été compares. Pendant les dchanges
hyperosmotiques, les deux agents produisaient un flux d'eau osmotique
significatif, mais aux concentrations molaires initiates qui etaient iden-
tiques, le flux observe avec le glycerol etait environ 40% moindre que
celui observe avec le glucose. 11 a dté trouvé que le plus faible volume
de transport géndré par le glycerol était dh a sa disparition ëtonnament
rapide du fluide péritoneal lorsqu'il était present a des concentrations
hyperosmotiques mais, paradoxalement, pendant les echanges isosmo-
tiques, lorsque sa concentration dtait faible, le glycerol n'était absorbd
que ldgérement plus vite que le glucose. L'augmentation observée de Ia
permeabilité peritoneale lorsque le glycerol était utilisé a entraine une
augmentation de deux fois de Ia charge calorique imposee par unite
d'eau enlevée en comparaison avec le glucose.
One of the clinical requirements in treating patients with
chronic renal failure is the removal of excess water. In peritone-
at dialysis this is achieved by the addition of a solute to the
dialysate which draws water out of the blood by osmosis.
Currently the sole osmotic agent in clinical use is glucose, but
this compound has two important disadvantages. First, appre-
ciable quantities of glucose diffuse from the dialysate into the
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blood [1—61, presenting the patient with a sizable and perhaps
undesirable caloric load [7—ill. Second, commercial peritoneal
dialysis solutions are sterilized using heat, and it is necessary to
acidify the solutions to prevent the sugar from caramelizing.
The resulting low pH of peritoneal dialysis solutions may cause
vasospasm and pain on infusion and irritate the peritoneum
[121. These shortcomings of glucose have prompted the search
for alternative osmotic agents, and studies using amino acid
mixtures [13, 141 and xylitol [121 have recently been reported.
Generally, the alternative osmotic agents tested have been
molecules larger than glucose whose ability to permeate the
peritoneum is less; however, such molecules have disadvan-
tages. Many are foreign metabolites and must be extensively
studied to establish their safety. The larger a molecule is, the
more weight of it must be used to achieve a required osmotic
driving force, and the large mass and molecule size of these
molecules raises the viscosity of their solutions. Thus, the
possibility of substituting a smaller molecule for glucose is
attractive; however, the advantages in mass per molecule and
solution viscosity could be offset by inadequate osmotic effec-
tiveness or too high a permeability through the peritoneum.
Glycerol is a potential small-molecule osmotic agent for perito-
neal dialysis.
The purpose of this study is to establish the osmotic effective-
ness and permeability of glycerol with respect to the rat
peritoneum to evaluate its usefulness as an osmotic agent in
peritoneal dialysis.
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Methods
Experimental strategy. In the first of three series of experi-
ments hyperosmotic exchanges were conducted in which vol-
ume transport was measured when either glucose or glycerol
was used as the osmotic agent. In the second series the diffusive
permeability of the peritoneum to tracer-labelled glucose and
glycerol was measured during isosmotic exchanges in the
absence of significant volume flow. In the third series the
concentration change of each osmotic agent was measured in
the osmotic flow it established during hyperosmotic exchanges.
Data from the first and third series were combined to produce a
record of changes in volume and concentration during hyperos-
motic exchanges from which estimates of peritoneal mass
transfer coefficients were made.
Preparation of animals. All experiments were performed on
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male Sprague-Dawley rats (Charles River Laboratories, Wil-
mington, Massachusetts), each weighing 441 to 546 g and
ingesting a standard rat chow diet and tap water ad libitum prior
to study. The animals were anesthetized by injecting mactin
(100 mg/kg) intraperitoneally and immobilized on a tempera-
ture-controlled surgical table. A tracheostomy was performed,
and the left jugular vein was cannulated with PESO tubing. An
infusion of normal saline at the rate of 6.6 mI/hr was begun 30
mm after the administration of the anesthetic and continued
throughout the balance of the experiment. The left femoral
artery was cannulated with PESO tubing filled with heparinized
saline to obtain arterial blood samples. A small incision was
made in the midline using a combination of electrocautery and
blunt dissection with fine tip forceps, and a PE2OS catheter [151
was inserted into the peritoneal cavity. Three animals in which
abdominal bleeding was noted during the experiment were
discarded.
One hour after the administration of the anesthetic 15 ml of
dialysate previously warmed to 37°C was gently injected into
the peritoneal cavity via the catheter: Approximately 1 mm was
required to deliver the entire bolus. Timed samples were
withdrawn after repeatedly flushing the catheter six times with
the peritoneal fluid. One animal in which dialysate leakage was
noted during the experiment was discarded.
Analytical methods. Dialysate volume changes were estimat-
ed by indicator dilution using blue dextran (Sigma Chemical
Company, St. Louis, Missouri), which has a molecular weight
of 2,000,000, as a marker [16—181. Absorbance readings of 2-mi
samples were obtained at 630 nm using a photometer (Enzac
Analyzer, Clay Adams, Parsippany, New Jersey). Osmotic
agent concentration changes were estimated using compounds
radioactively labelled (New England Nuclear Corporation, Bos-
ton, Massachusetts) as described further below. Samples (20 tl
each) of peritoneal fluid (that is, dialysate) or plasma were
transferred using an adjustable Finnpipette into 10 ml of Bio-
fluor Emulsifier Cocktail (New England Nuclear Corporation)
and counted for I mm in a liquid scintillation spectrometer (Tn-
Carb Model 2001, Packard). The counts per minute were
reduced to disintegrations per minute by corrections for back-
ground counts and counting efficiency.
Statistical methods. The reduced data were analyzed using
analysis of variance, least squares regression, analysis of co-
variance, and paired and unpaired t tests. A P value less than
0.05 was adopted as the criterion for the significance of ob-
served differences.
Series 1 volume transients during hyperosmotic exchanges.
The dialysate for these experiments consisted of 0.1% blue
dextran in Ringer's lactate to which was added either nothing
(four animals), glycerol to a level of 2.2 wt % (three animals), or
glucose to a level of 4.3 wt % (three animals). Two-milliliter
samples were obtained 15, 30, 45, and 60 mm after administer-
ing the dialysate. Absorbance readings were made.
To estimate peritoneal volume changes, it was assumed that
all the blue dextran except that removed by sampling remained
within the peritoneal cavity. From a mass balance on the
impermeant dextran:
or
c(t1) VD(tl) c(t2) VD(t2)
VD(t2)/VD(tI) = c(t1)/c(t2)
and since the dextran solutions were found to obey the Lam-
bert-Beer law:
VD(t2)/VD(tl) = Absorbance(t1 )/Absorbance(t2). (3)
Corrections were made for volume losses due to sampling.
Series 2 solute transients during isomotic exchanges. The
dialysate for this series was Ringer's lactate to which was added
I Ci each of either [2-3H]-glyceroi and D-[14C(U)j-glucose
(three animals) or [l,3J4C]-glycerol and D-[3-3HJ-glucose
(three animals). Samples (200 p1 each) of peritoneal fluid were
drawn 10, 20, 30, and 40 mm after administering the dialysate.
Blood samples (200 p1 each) were drawn immediately before
administering the dialysate and 20 and 40 mm later. Blood was
drawn into 50-p1 heparinized glass tubes by capillary action,
and plasma was separated from erythrocytes by centrifugation.
Plasma and dialysate samples were analyzed for 3H and 14C
activity. Losses due to sampling were negligible in this series of
experiments, and no corrections were made.
If the transperitoneal flow of volume is assumed to be
negligible, a mass balance on the dialysate osmotic agent gives:
dC1/dt = [(PmA)/VD] (CB — CD). (4)
Throughout these experiments the plasma counts observed
were small compared to the dialysate counts. Neglecting them
equation (4) can be integrated to obtain:
lfl[CD(t)/CD(O)J = [(PmA)/VDIt. (5)
The dialysate osmotic agent concentration was assumed to be
proportional to the calculated disintegrations per minute, and
least squares techniques were used to estimate the slope of a
semilog regression of the disintegrations per minute ratio
against time. Diffusive permeability estimates were then ob-
tained as the product of the slope of the regression line and
-VD.
We were concerned that metabolism of the osmotic agent
might complicate the interpretation of the transport data, and to
evaluate this factor we labelled each osmotic agent in two
different ways. Data for animals receiving a given label were
pooled, and the group regression slopes were compared, using
an analysis of covariance, and found not to be significantly
different. We interpreted this result as indicating that it was
unlikely that significant intraperitoneal metabolism of the os-
motic agents was occurring, and in the subsequent analysis the
data for the two labels were pooled.
Series 3 osmotic agent transients during hyperosmotic ex-
changes. The dialysate for this series was 0.1% blue dextran in
Ringer's lactate, containing either 2.2% glycerol or 4.3% glu-
cose, to which was added I Ci of either 3H-glycerol or
glucose, respectively. Samples (400 1d each) of peritoneal fluid
were obtained 5, 10, and 20 mm after administering the dialy-
sate. Blood samples (200 p1 each) were drawn immediately
before and 20 mm after the administration of the dialysate.
Plasma and dialysate samples were analyzed for 3H activity.
The raw data were reduced to concentration ratios prior to
statistical analysis. Sampling losses were too small in this series
to have a significant impact on the results and were neglected.
(1) Using the combined data from series 1 and 3, peritoneal mass
transfer coefficients were estimated by computer simulations
using a pharmacokinetic model which is described in the
(2) Appendix. A set of mass transfer coefficients was chosen, and
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glucose. The lower volume transport per mole injected might be
due to an accelerated dissipation of the concentration difference
between dialysate and blood and/or a smaller volume flow at a
given concentration difference. The second series of experi-
ments was designed to compare the diffusive permeabilities of
glycerol and glucose under conditions where the influence of
the hydraulic permeability and reflection coefficient was unim-
portant. Diffusive permeability estimates were obtained by
separate regression analysis of the data for each osmotic agent
in each animal, and the results for each osmotic agent were
averaged. All the slope estimates were significantly different
from zero as measured by t tests.
The permeability estimate obtained during isosmotic ex-
changes was 0.35 0.02 ml/min for glucose, and the glycerol
estimate was 0.40 0.02 mI/mm. The difference between the
diffusive permeability estimates for the two osmotic agents in
each animal was calculated, and a paired (test indicated that the
difference was significantly different from zero. Although the
diffusive permeability of glycerol was significantly greater than
that of glucose during isosmotic exchanges, the difference was
small, about 15%, and could not have been demonstrated in the
absence of pairing.
Series 3. The purpose of the third series of experiments was
to compare the rate of absorption of glucose and glycerol from
the peritoneal cavity during hyperosmotic exchanges. At each
time point the mean glycerol concentration ratio was found to
be significantly less than the mean glucose concentration ratio
using an unpaired t test. Although plasma counts did increase
during the course of these experiments, they were negligible in
comparison with the dialysate counts. Taken together these two
findings indicate that the concentration difference between
dialysate and plasma dissipated more quickly in the experi-
ments in which glycerol was used as the osmotic agent than it
did when glucose was used.
Peritoneal mass transfer coefficient estimates for the hyper-
osmotic exchange experiments were obtained by computer
simulation, The results of these simulations are illustrated in
Results Figures 2 and 3 together with the reduced data from the first and
third series of experiments.
In the hyperosmotic glucose exchange experiments, the
dialysate osmotic agent concentration ratio decreased more
slowly than it did in the isosmotic exchange experiments. The
optimal diffusive permeability estimate for glucose was 0.26
mI/mm, a value 25% lower than the mean from the isosmotic
exchange experiments and outside its 95% confidence band
(0.31 < PA < 0.39). However, the difference in both the
predictions of the model and the values of the other two mass
transfer coefficients using the two different values of the
diffusive permeability was too small to warrant concern. The
optimal hydraulic permeability estimate was 174 (nl/min)/(mm
Hg), and the reflection coefficient estimate was 0.37.
In contrast with glucose, in the hyperosmotic glycerol ex-
change experiments the dialysate osmotic agent concentration
ratio decreased more quickly than it did during isosmotic
exchanges. The optimal diffusive permeability estimate for
glycerol was 0.86 mI/mm, a value more than double the mean
from the isosmotic exchanges. The optimal hydraulic perme-
ability estimate with glycerol was 249 (nl/min)/(mm Hg), more
than 40% greater than that obtained with glucose. The optimal
reflection coefficient estimate for glycerol was 0.28, a value
>
180
160
140
120
100
80
Time, mm
Fig. 1. Peritoneal fluid volume transients observed in the first series of
experiments. Each point is the mean 2 SEM.
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the model equations were integrated numerically using a fourth
order Runge-Kutta algorithm implemented in FORTRAN [19].
The computer-generated predictions of the time course of the
dialysate volume and osmotic agent concentration ratios could
be compared with the experimental data obtained in series 1 and
3. The goodness of fit was assessed by calculating the sum of
the squares of the deviations of the data points from the model
predictions. Each of the mass transfer coefficients was varied in
succession [20] until the sum was minimized.
Series 1. The purpose of the first series of experiments was to
determine whether glycerol was osmotically effective. The
reduced data for the three groups are depicted in Figure 1. At
any time point the estimated dialysate volume in the control
group was not significantly different from that injected. In
contrast, at each time point the volume of a dialysate initially
containing 240 mM glycerol was significantly greater than that
injected, and the estimated mean volume increased with time.
The results for each time point were compared between glycer-
ol and glucose groups using unpaired (tests, and at each time
point the volume of a dialysate initially containing 240 m
glucose was found to be significantly greater than that of a
dialysate initially containing 240 mrvi glycerol.
These results indicate that glycerol is an effective osmotic
agent in this model of peritoneal dialysis. Over the course of an
hour the volume of the glycerol dialysate increased by about
35%. However, glycerol is less effective mole for mole than is
glucose which gave nearly a 60% volume increase in the same
time span.
Series 2. Having established the osmotic effectiveness of
glycerol, we investigated the mechanisms responsible for the
different volume transport it generated in comparison with
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Fig. 2. Results of pharmacokinetic model simulation of a hyperosmotic
glucose exchange. The upper curve depicts the intraperitoneal volume,
transient predicted by the model and the experimental data (X) obtained
in the first series of experiments. The lower curve depicts the predicted
intraperitoneal osmotic agent concentration transient and the experi-
mental data obtained in the third series of experiments (0). Both plots
have been normalized by dividing by the values at t = 0.
smaller than the corresponding estimate for glucose, as was
expected.
Finally, it will be noted that the product of the reflection
coefficient and the hydraulic permeability expresses the volume
flow per unit concentration difference between dialysate and
blood. Since the value of this product was comparable for the
two agents, 64 versus 70 (nl/min)/(mm Hg), it can be concluded
that at any given concentration difference the volume flow
produced by glucose and glycerol was also comparable. Thus,
the diminished cumulative volume transport generated by glyc-
erol can be attributed entirely to an accelerated dissipation of
the concentration difference.
Discussion
This study demonstrates that a molecule smaller than glucose
can induce significant osmotic transport of water across the
peritoneum, a finding which reveals an entire class of com-
pounds not previously considered for use as alternative osmotic
agents in peritoneal dialysis. However, because glycerol had an
unexpected and unfavorable effect on peritoneal permeability,
at osmotically effective concentrations, it did not achieve the
benefit expected from such compounds: decreased caloric load.
Recognizing that the caloric equivalent of glycerol is nearly
the same as that of glucose on a weight basis [21], the caloric
load imposed in the process of removing water can be estimated
from the results of this study by calculating the amount of water
extracted into the peritoneal cavity per gram of osmotic agent
absorbed. At any time t this ratio equals:
{V(t)/V(O) — l}I{c(O)[l — (c(t)V(t)/c(O)V(O))]}.
Using the curves in Figures 2 and 3, the value of this ratio is
nearly constant over a 1-hr period and is about 37 mug absorbed
Fig. 3. Results of pharmacokinetic model simulation of a hyperosmotic
glycerol exchange. The upper curve depicts the intraperitoneal volume
transient predicted by the model and the experimental data (X) obtained
in the first series of experiments. The lower curve depicts the predicted
intraperitoneal osmotic agent concentration transient and the experi-
mental data obtained in the third series of experiments (0). Both plots
have been normalized by dividing by the values at t = 0.
for glucose and about 20.5 mUg absorbed for glycerol. By this
criterion glucose is thus almost twice as effective an osmotic
agent as glycerol.
The peritoneal mass transfer coefficients obtained in the rat in
this study cannot be directly compared with previous estimates
obtained in clinical studies. However, by assuming that the
intrinsic permeability of the peritoneum (that is, L and Pm) is
comparable in both species, and that the peritoneal surface area
(A) is proportional to body weight to the two-thirds power [22],
quantitative extrapolations of the overall mass transfer coeffi-
cients, that is, (PmA) and (LA), can be made. The surface area
scaling factor, (70 kg/0.5 kg)213, is about 27. Since glycerol has
not been studied previously only glucose will be considered.
Multiplication of the overall diffusive permeability estimates
obtained in this study during isosmotic and hyperosmotic
exchanges by the area scaling factor gives an extrapolated value
in humans of 7.0 and 9.5 ml/min, respectively. Within the limits
of experimental error, these estimates are identical to those
obtained by Pyle [20] in patient studies: 9.8 2.7 nil/mm. The
reflection coefficient is independent of the area and thus no
correction is required. The value obtained in the present study,
0.37, is consistent with the estimates obtained in patient studies
by Pyle [20]: 0.45 0.3. Finally, the overall hydraulic perme-
ability estimate obtained in this study extrapolates to a value in
humans of 4.7 (il/min)/(mm Hg). No direct estimates of this
coefficient have been reported, although Bomar [23] used a
value of the same order of magnitude (about twice as large) in
the simulations reported in his dissertation. Thus, it appears
that the results obtained in the animal model studied here can be
extrapolated to clinical peritoneal dialysis with a fair degree of
confidence.
Accordingly, we would anticipate that a hyperosmotic glycer-
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ol dialysate would have the same deleterious impact on perito-
neal permeability in patients as it did in the animals we studied,
and we therefore cannot recommend the use of this osmotic
agent in the general patient population. Indeed the only sub-
group that we can envision might benefit from the substitution
of glycerol for glucose is insulin-dependent diabetic patients.
However, an analysis of the postabsorption metabolism of
glycerol in this subgroup would have to be undertaken before
such a recommendation could be made.
Finally, it is of interest to note that some years ago Hender-
son and Nolph [241 reported increases in peritoneal permeabili-
ty following exposure to a dialysis fluid containing 7% glucose.
In the present study similar results were obtained when 2.2%
glycerol was used, but 4.3% glucose caused no observable
increase over that measured at tracer levels.
In summary, isosmotic and hyperosmotic exchanges were
conducted in anesthetized rats to evaluate glycerol as an
alternative osmotic agent for peritoneal dialysis. The results
indicated that glycerol was capable of generating a significant
osmotic flow of water. However, at osmotically effective con-
centrations the rapid rate at which glycerol was absorbed from
the peritoneal cavity resulted in an increased caloric load per
unit of water removed in comparison with glucose.
Appendix
Theoretical framework for the analysis of mass transport in
peritoneal dialysis
The methods utilized to analyze mass transfer data obtained
in peritoneal dialysis experiments are the subject of a recent
review [251. Most commonly results obtained in a clinical
setting have been reported as clearances and occasionally as
clialysances. Although such data are adequate to judge the
efficacy of therapy, they provide no insight into underlying
transport mechanisms.
The analysis of solute and water transport transients in the
present study was based on the theory of irreversible thermody-
namics as applied to membrane processes [20, 23, 26—30]. The
model system consists of two compartments which represent
the intraperitoneal dialysate (subscript D) and the body fluids of
the rat (subscript B). Each compartment is characterized by its
volume (V) and osmotic agent concentration (C), and it is
assumed that the composition of each compartment is uniform.
Mass transfer between the compartments occurs through the
peritoneum which is modelled as a single homogeneous mem-
brane. Water traverses the membrane by osmosis as a result of
osmotic agent concentration differences between the compart-
ments. The osmotic agent traverses the membrane both by
diffusion down concentration gradients within the membrane
and also by convective transport associated with the water
flow, that is, solvent drag. It is assumed that hydrostatic and
oncotic pressure gradients can be neglected [23, 311, that the
osmotic agent forms an ideal aqueous solution in the sense of
van't Hoff's law, and that only the flows of water and osmotic
agent need be considered. Considering these assumptions, the
following expressions for the transmembrane flows of volume,
(Q) and osmotic agent, (Q), can be derived [20, 23, 32—36]:
Q = -(LA)RT(CB - CD)
Q = (PmA) (CB CD) + C(l —
where R is the gas constant, T is the absolute temperature, and
C is a weighted average of the osmotic agent concentrations in
the two compartments. Thus, the mass transfer characteristics
of a given membrane-osmotic agent pair are characterized in
this model by three mass transfer coefficients: the diffusive
permeability (PmA), the reflection coefficient (s), and the
hydraulic permeability (LA). Given a concentration difference
(CB — CD), the quantity (PmA) reflects the tendency of the
osmotic agent to enter the blood by diffusion, while the quantity
(LA) measures the capacity of the osmotic agent to produce a
volume flow. The term C(l — I)Q reflects the movement of the
osmotic agent coupled to the volume flow.
Equations (1) and (2) report instantaneous flows of osmotic
agent and volume. When (PmA), (LA), and I are known, these
equations can be combined with initial compartmental volumes
and concentrations and integrated to produce estimates of
changes in compartmental volumes and concentrations over
time. Conversely, measurements over time of peritoneal dialy-
sate volume and the concentration of osmotic agent in dialysate
and blood can be used to estimate (PmA), (LA), and I.
Mass transfer coefficient estimates for the hyperosmotic
exchange experiments reported in the text were obtained by
computer simulation. The body fluids of the rat were modelled
as a single well mixed compartment with a constant volume of
300 ml. Model equations were obtained by separate mass
balances on the osmotic agent in the peritoneal fluid and the
body fluids, as well as an overall mass balance on the peritoneal
fluid [28]:
• Overall mass balance on peritoneal fluid
dVD/dt Q
• Mass balance on osmotic agent in body fluids
dCB/dt =
—Q/V8
• Mass balance on osmotic agent in peritoneal fluid
dCD/dt = [Q — CDdVD/dtj/VD
Substitution of the rate equations (1) and (2) into the mass
balance equations yields expressions which contain only the
measurable quantities, YD, CD, CB, and the unknown mass
transfer coefficients, (PmA), (LA), and I.
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